The purpose is to award a delivery order under IDIQ 75F40121D00007 to purchase specific supplies/reagents for the pacbio sequel IIE long-read DNA/RNA sequencer.
Ended Awarded Last action
- Contract number
- 75F40126F19009
- Awardee
-
Pacific Biosciences Of California, Inc. UEI CP22V46XYQK6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $47,897
Award facts
- Contract value 100% obligated
- $47,897.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $47,897.16 delivery order to Pacific Biosciences of California, Inc. on March 30, 2026, for supplies and reagents supporting the PacBio Sequel IIe long-read DNA/RNA sequencer. This delivery order was issued under the FDA's existing Indefinite Delivery Indefinite Quantity (IDIQ) contract 75F40121D00007 with Pacific Biosciences, valued at $1 million and originally extending through March 2025. The work will be performed in Laurel, Maryland, with an ultimate completion date of September 28, 2026. The contract is structured as a firm fixed-price engagement with no small business set-aside designation.
Pacific Biosciences is a leading biotechnology manufacturer specializing in advanced sequencing technologies and consumables, and this delivery order represents continued procurement of critical laboratory supplies for the FDA's genomic research and regulatory science initiatives. The supplies procured under this order will support the agency's genomic research, regulatory review activities, and food safety initiatives at facilities including the National Center for Toxicological Research and Centers for Food Safety and Applied Nutrition. This award reflects the FDA's ongoing reliance on Pacific Biosciences' Sequel platform consumables, which have proven essential to the agency's scientific mission across multiple regulatory and research programs.
Quick answers
Who was awarded contract 75F40126F19009?
75F40126F19009 was awarded to Pacific Biosciences Of California, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 30, 2026.
How much is contract 75F40126F19009 worth?
The government has obligated $47,897 on 75F40126F19009.
Is contract 75F40126F19009 an order under another contract?
Yes. 75F40126F19009 is a delivery order under 75F40121D00007, an indefinite delivery contract.
Was contract 75F40126F19009 competed?
The extent of competition for 75F40126F19009 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award